Surface structure of fly ash particles. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Elemental composition of Fly Ash. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Composition of LM6 alloy. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Image of the prepared sample (Pins and Disc). حسب Charles Sarala Rubi (21608723)

الموضوعات:

Micrograph of worn pin of LM6 alloy. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Response graphs for GRG. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Effect of B₄C& Fly ash on the hardness of AMCs. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Flowchart of patient selection in this study. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

S1 Data - حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Clinical course of patient no. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Socio-demographic and medical characteristics of patients with liver cancer. حسب Ayana Ablayeva (22103708)

الموضوعات:

Data cleaning and preparation algorithm. حسب Ayana Ablayeva (22103708)

الموضوعات:

Upcycling of Postconsumer Recyclate Polypropylene into Low Warping and High Toughness 3D Printable Filaments حسب Animesh Gopal (18521180)

الموضوعات:

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. حسب Ayana Ablayeva (22103708)

الموضوعات: